Vaxine R & D Strengths

Vaxine has an ever-growing pipeline of vaccines for human and veterinary use. Thanks to over 10 years experience with our Advax™ adjuvant, our staff understand every stage of product development, from pre-clinical testing through to human clinical trials. This insight into the full life cycle of a new vaccine product is an invaluable asset for the company, especially when assessing the potential of an innovative technology at a pre-clinical stage. Vaxine’s success in bringing innovative vaccines through to human clinical trials has been largely driven by our ability to design systems that allow a full and rigorous assessment of safety and efficacy using both in vitro and in vivo models and careful selection of the very best early-stage vaccine projects with the potential to become successful human vaccines of the future.